Sign-up For Updates

DIPG Clinical Trials

Trials - Current as of: 2020-10-23

70 clinical trials across 15 countries:

Clinical Trial
Sponsor
Country
Switzerland United States of America
Switzerland United States of America University of California, San Francisco

Fimepinostat in Treating Brain Tumors in Children and Young Adults
Last Updated: 2020-10-13
Originally Posted: 2019-03-26

United States of America
United States of America Actuate Therapeutics Inc.

9-ING-41 in Pediatric Patients With Refractory Malignancies.
Last Updated: 2020-10-02
Originally Posted: 2020-01-20

United States of America
United States of America National Cancer Institute (NCI)

Volitinib in Treating Participants With Recurrent or Refractory Primary CNS Tumors
Last Updated: 2020-09-23
Originally Posted: 2018-07-24

United States of America
United States of America Pediatric Brain Tumor Consortium

Phase I Study of APX005M in Pediatric CNS Tumors
Last Updated: 2020-09-17
Originally Posted: 2017-12-15

United States of America
United States of America Dana-Farber Cancer Institute

Phase I Study of Marizomib + Panobinostat for Children With DIPG
Last Updated: 2020-09-14
Originally Posted: 2020-03-05

United States of America
United States of America University of California, San Francisco
United States of America
United States of America Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
United States of America
United States of America Oncoceutics, Inc.

ONC201 in Pediatric H3 K27M Gliomas
Last Updated: 2020-09-08
Originally Posted: 2018-01-23

United States of America
United States of America University of California, San Francisco
United States of America
United States of America University of California, San Francisco
United States of America
United States of America National Institutes of Health Clinical Center (CC)
United States of America
United States of America Nationwide Children's Hospital
United States of America
United States of America Augusta University
United States of America
United States of America Children's National Research Institute
United States of America
United States of America Ziopharm
United States of America
United States of America Stanford University
China
China Shenzhen Geno-Immune Medical Institute

Immune Modulatory DC Vaccine Against Brain Tumor
Last Updated: 2020-06-10
Originally Posted: 2019-04-11

Italy
Italy Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses
Last Updated: 2020-06-08
Originally Posted: 2018-05-14

Germany
Germany Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen
United States of America
United States of America Pediatric Brain Tumor Consortium

INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
Last Updated: 2020-05-27
Originally Posted: 2020-02-27

United States of America
United States of America Emory University

Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Last Updated: 2020-04-01
Originally Posted: 2015-12-15

India
India Tata Memorial Centre
United States of America
United States of America Weill Medical College of Cornell University
United States of America
United States of America Pediatric Brain Tumor Consortium

Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
Last Updated: 2020-03-03
Originally Posted: 2016-02-22

United States of America
United States of America Baylor College of Medicine

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Last Updated: 2020-02-20
Originally Posted: 2019-09-20

United States of America
United States of America Columbia University

CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas
Last Updated: 2020-02-18
Originally Posted: 2020-02-07

United States of America
United States of America Children's Hospital Medical Center, Cincinnati
United States of America
United States of America University of Colorado, Denver

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
Last Updated: 2019-09-25
Originally Posted: 2016-11-29

United States of America
United States of America Pediatric Brain Tumor Consortium
Australia
Australia Dr. David Ziegler
Canada
Canada University of Calgary

Re-Irradiation of Progressive or Recurrent DIPG
Last Updated: 2019-04-22
Originally Posted: 2017-04-19

United States of America
United States of America Northwell Health

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Last Updated: 2019-03-22
Originally Posted: 2013-04-16

United States of America
United States of America University of Cincinnati

Hypofractionated Radiotherapy for Recurrent DIPG
Last Updated: 2019-02-13
Originally Posted: 2019-02-12

Germany
Germany University of Göttingen

International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
Last Updated: 2018-08-07
Originally Posted: 2017-08-04

France
France Gustave Roussy, Cancer Campus, Grand Paris

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Last Updated: 2018-07-20
Originally Posted: 2014-08-29

Netherlands
Netherlands VU University Medical Center

11c-erlotinib Brain Uptake In Diffuse Intrinsic Pontine Glioma Imaged By Pet
Last Updated: 2018-05-04
Originally Posted: 2018-05-04

Italy
Italy Meyer Children's Hospital
Netherlands
Netherlands Gustave Roussy

Biological Medicine For Diffuse Intrinsic Pontine Glioma (dipg) Eradication
Last Updated: 2017-08-01
Originally Posted: 2017-08-01

United Kingdom
United Kingdom Gustave Roussy
Spain
Spain Clínica Universidad de Navarra
Sweden
Sweden Gustave Roussy

Biological Medicine For Diffuse Intrinsic Pontine Glioma (dipg) Eradication
Last Updated: 2016-06-22
Originally Posted: 2016-06-22

Denmark
Denmark Gustave Roussy

Biological Medicine For Diffuse Intrinsic Pontine Glioma (dipg) Eradication
Last Updated: 2015-09-16
Originally Posted: 2015-09-16

Netherlands
Netherlands VU University Medical Center

A Comprehensive And Targeted Therapy Approach In Pediatric Malignant Pontine Gliomas
Last Updated: 2010-06-09
Originally Posted: 2010-06-09


Sign-Up For Updates

* indicates required
BETA: Clinical Trial Updates (When They Become Available)
General Updates

Content courtesy of clinicaltrials.gov, clinicaltrialsregister.eu, and anzctr.org.au